68Ga-PSMA-11 PET/CT in Primary and Recurrent Prostate Carcinoma: Implications for Radiotherapeutic Management in 121 Patients-Reference-Cited by-同舟云学术

68Ga-PSMA-11 PET/CT in Primary and Recurrent Prostate Carcinoma: Implications for Radiotherapeutic Management in 121 Patients

Published:2018-07-05 Issue:2 Volume:60 Page:234-240
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Koerber Stefan A.,Will Leon,Kratochwil Clemens,Haefner Matthias F.,Rathke Hendrik,Kremer Christophe,Merkle Jonas,Herfarth Klaus,Kopka Klaus,Choyke Peter L.,Holland-Letz Tim,Haberkorn Uwe,Debus Juergen,Giesel Frederik L.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference27 articles.

1. The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

2. Pelvic lymph node dissection for nodal oligometastatic prostate cancer detected by 68 Ga-PSMA-positron emission tomography/computerized tomography

3. Intra-individual comparison of 68Ga-PSMA-11-PET/CT and multi-parametric MR for imaging of primary prostate cancer

4. Sensitivity, specificity, and predictors of positive 68Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis;Perera;Eur Urol.,2016

5. 68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT;Bluemel;Clin Nucl Med.,2016

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparative study of 18F-PSMA-1007 PET/CT and pelvic MRI in newly diagnosed prostate cancer;BMC Medical Imaging;2024-07-30

2. 68Ga-PSMA;Radiopharmaceuticals;2024

3. Impact of⁶⁸Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers;Journal of Nuclear Medicine;2023-09-07

4. PSMA PET/CT and PET/MRI in primary staging of prostate cancer and its effect on patient management;Clinical and Translational Imaging;2023-08-30

5. Prostate specific membrane antigen positron emission tomography in primary prostate cancer diagnosis: First-line imaging is afoot;Cancer Letters;2022-11